• Memorial Sloan Kettering's pilot blood test detects 50 types of cancer

    Results from a pilot study led by New York City-based Memorial Sloan Kettering Cancer Center suggest that a single blood test may be able to detect the presence of 50 different cancer types, according to an Oct. 13 news release. 
  • Manage growth demands without burdening staff: A modern strategy for oncology practices

    Manage higher volumes without burdening staff: Get best practices from an oncology center's success here.
  • 7 cancer trends to know

    More than 1.9 million people are estimated to develop new cancer cases and more than 609,000 are estimated to die of cancer in 2023, according to estimates compiled by the American Cancer Society.
  • HCA hospital 1st to test new brain cancer treatment

    HCA Healthcare's Johnston-Willis Hospital in Richmond, Va., is the first in the nation to provide a new treatment for patients with brain metastases from lung cancer.
  • Resilience in action: Creating lasting change at infusion centers

    Traditional operational strategies don't cut it for infusion centers. Hear how Duke Health innovated its processes to boost efficiency + nurse and patient satisfaction here.
  • AI in the OR: How a new tool can aid brain surgeons during procedures

    An emerging artificial intelligence-powered tool, known as Sturgeon, successfully diagnosed 45 out of 50 frozen brain tumor samples in a matter of just 40 minutes. In living patients, the tool was capable of accurately diagnosing 18 out of 25 cases, according to a study published Oct. 11 in Nature.
  • How Karmanos built a more accurate cancer risk assessment tool

    Detroit-based Karmanos Cancer Institute launched a questionnaire that identifies high-risk cancer patients with a few extra questions.
  • Researchers predict prostate cancer recurrence 15 months faster with new model

    The recurrence of prostate cancer can now be detected 14.8 months sooner than existing clinical practices with new technology developed by a professor at Purdue University in West Lafayette, Ind.
  • Johns Hopkins, Allegheny Health end cancer partnership

    After nine years, Baltimore-based Johns Hopkins and Pittsburgh-based Allegheny Health Network have announced that they will end their cancer center collaboration, TribLive reported Oct. 6.
  • City of Hope tests robot-assisted mastectomies

    Duarte, Calif.-based City of Hope will open the first multicenter clinical trial in the U.S. to test robotically assisted mastectomies, according to an Oct. 3 news release shared with Becker's.
  • Long-time oncology leader retires

    Hung-Chi Ho, MD, a board-certified radiation oncologist at University of Pittsburgh Medical Center's Hillman Cancer Center in Butler, Pa., will retire after a 37-year career with the health system.
  • Mayo Clinic using AI to detect pancreatic cancer

    Rochester, Minn.-based Mayo Clinic is utilizing artificial intelligence to achieve earlier detection of pancreatic cancer in patients while the disease is still curable, according to an Oct. 2 news release.
  • Diabetes lowers survival chances in some blood cancer patients

    Patients who have multiple myeloma and also diabetes are at an increased risk of lower survival rates, but new research shows this differs by race.
  • The top oncology concerns right now

    Healthcare professionals said health disparities and inadequate treatment options are their top concerns in oncology, according to a recent poll from Becker's on LinkedIn.
  • 6 cancers were underdiagnosed in 2020

    Six types of cancer were underdiagnosed during the pandemic, according to the National Institutes of Health.
  • Mass General Cancer Center gets largest donation in history

    Boston-based Mass General Cancer Center has received the largest philanthropic gift in its history to be put toward future cancer research, according to a Sept. 27 news release.
  • How this oncology leader is increasing care access for rural patients

    Joseph Rosales, MD, was considering a few different specialties during training, but what drew him to oncology was the ability to have "very close and intense relationships with patients."
  • Serious side effect more common for this breast cancer drug

    New York City-based Memorial Sloan Kettering Cancer Center researchers found higher rates of hyperglycemia in patients treated with a common breast cancer medication than reported in the original clinical trial submitted to the FDA.
  • Researchers uncover mechanism of rare cancer

    A Honolulu-based University of Hawai'i Cancer Center study found HMGB1 protein in asbestos is linked to development of mesothelioma, a rare cancer.
  • 2nd pediatric patient gets ultrasound treatment for brain tumor

    A 6-year-old with a brain tumor at Children's National Hospital in Washington, D.C., has become the second pediatric recipient of an ultrasound treatment for this particular type of cancer, The Washington Post reported Sept. 25.
  • How Ultrasound With AI Could Improve Breast Cancer Screening for Up to 40% of Women

    Donna Dunn has always been good about getting her annual mammogram, especially since her husband died almost 10 years ago from a heart attack, leaving her as her adult daughter’s sole support. Now she also helps with her 9- and 11-year-old granddaughters, shuttling them to and from gymnastics and basketball practice.
  • Virginia cancer center to get new name

    Virginia Commonwealth University's Massey Cancer Center in Richmond, Va., announced a name change, Sept. 20. It will now become the "VCU Massey Comprehensive Cancer Center." 

Featured Whitepapers

Featured Webinars